798 studies found for:    pharmacogenomics OR pharmacogenetics
Show Display Options
Download search resultsDownload the search results for:
pharmacogenomics OR pharmacogenetics (798 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Completed Implementation of a Personalized Medicine (Pharmacogenomics) Service in a Community Pharmacy
Conditions: Stroke;   Transient Ischemic Attack;   Myocardial Infarction
Intervention: Other: Pharmacogenomics testing for clopidogrel responsiveness
2 Active, not recruiting Pharmacogenomics and Effective Treatment With Clopidogrel
Condition: Pharmacogenomics
Intervention: Genetic: Pharmacogenomics
3 Not yet recruiting A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program
Condition: Adverse Drug Reaction
Intervention: Device: Pharmacogenetic Intervention Arm (pharmacogenetic testing)
4 Completed
Has Results
Applying Pharmacogenetic Algorithms to Individualize Dosing of Warfarin
Condition: Thromboembolism
Interventions: Genetic: IWPC adapted genotype-guided dosing algorithm for warfarin;   Genetic: Modified IWPC genetic-guided warfarin dosing algorithm;   Other: Standard of care treatment
5 Completed Antidepressant Treatment of Mexican-Americans: UCLA Pharmacogenetics and Pharmacogenomics Research Group
Conditions: Major Depressive Disorder;   Major Depression;   Unipolar Depression
Intervention: Drug: fluoxetine or desipramine
6 Recruiting Applying Pharmacogenetics to Warfarin Dosing in Chinese Patients
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Pulmonary Embolism;   Heart Valve Disease
Interventions: Other: Genotype-guided warfarin dosing;   Other: Non-genotype guided warfarin dosing
7 Not yet recruiting Pharmacogenomics Registry to Assess Clinical Utility
Condition: Drug Side Effects
Intervention:
8 Completed Renal Function and Pharmacogenetics in Renal Transplant Recipients Converted From Tac BID to Tac OD
Conditions: Real Function Post Conversion From Prograf to Advagraf;   Examin Ethnicity and Pharmacogenetics of the Cohort Requiring Dose Adjustment Post-conversion
Intervention:
9 Completed
Has Results
Comparison of Warfarin Dosing Using Decision Model Versus Pharmacogenetic Algorithm
Conditions: Atrial Fibrillation;   Pulmonary Embolism;   Deep Vein Thrombosis
Intervention: Genetic: Warfarin Dose based on pharmacogenetics
10 Active, not recruiting Pharmacogenetic Testing in Primary Care
Condition: Pharmacogenetic Testing
Intervention:
11 Not yet recruiting The Implementation of Pharmacogenomics Into Primary Care in British Columbia
Condition: Pharmacogenetics
Intervention: Other: Decision support
12 Completed Clinical and Economic Impact of an Electronic Medical Record Interfaced Decision Support System Reinforced With Patient Specific Pharmacogenetic Data for Minimizing Severe Drug-Drug Interactions
Condition: Healthcare
Intervention: Other: DDI+ System and Pharmacogenetic Data
13 Unknown  Validation of Pharmacogenetics Plus Drug Combination Guided Initial Tacrolimus Dosage in Renal Transplant Recipients
Condition: Renal Transplantation
Interventions: Other: drug (tacrolimus and SchE) and genetics;   Drug: tacrolimus
14 Recruiting Utility of PharmacoGenomics for Reducing Adverse Drug Effects
Condition: Genetics of Drug Metabolism
Intervention:
15 Recruiting Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)
Condition: Bipolar Affective Disorder
Intervention: Drug: Mood stabilizer treatment
16 Unknown  Pharmacogenomics Studies of Antidepressants
Conditions: Major Depressive Disorder;   Antidepressive Agents;   Pharmacogenetics;   Venlafaxine;   Fluoxetine
Interventions: Drug: Venlafaxine;   Drug: Fluoxetine
17 Completed Pharmacogenomics Validation for Imatinib in Chronic Myeloid Leukemia
Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Intervention:
18 Completed Pharmacogenetics of Warfarin in Puerto Ricans.
Conditions: Atrial Fibrillation;   Deep Vein Thrombosis;   Cardiac Valvular Insufficiency;   Antiphospholipid Syndrome;   Coagulopathy
Intervention:
19 Completed Pharmacogenomic of Atazanavir/Efavirenz (ATV/EFV)
Condition: HIV Infections
Intervention:
20 Recruiting Pharmacogenetic Testing Among Home Health Patients
Conditions: Adverse Drug Events;   Adverse Drug Reactions;   Drug Interaction Potentiation;   Drug Metabolism, Poor, CYP2D6-RELATED;   Drug Metabolism, Poor, CYP2C19-RELATED;   Cytochrome P450 Enzyme Deficiency;   Cytochrome P450 CYP2D6 Enzyme Deficiency;   Cytochrome P450 CYP2C9 Enzyme Deficiency;   Cytochrome P450 CYP2C19 Enzyme Deficiency;   Cytochrome P450 CYP3A Enzyme Deficiency;   Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant;   Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant;   Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant
Intervention: Genetic: Pharmacogenetic testing

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years